Receive our newsletter – data, insights and analysis delivered to you
  1. Research Reports
February 21, 2017

Gastric Balloon market threatened by safety concerns raised by FDA

The FDA has announced that they have received several reports of adverse events in patients using the Orbera and ReShape gastric balloons since their approval in the US 18 months ago.

By GlobalData Healthcare

The FDA has announced that they have received several reports of adverse events in patients using the Orbera and ReShape gastric balloons since their approval in the US 18 months ago.

Gastric balloons are a non-surgical short-term weight loss device, implanted through the mouth and filled with saline to occupy a portion of the stomach’s volume.

The two safety concerns reported by the FDA are over-inflation and acute pancreatitis. Over-inflation, an issue that is not currently addressed on the product’s labeling, has been reported to cause abdominal pain and swelling, difficulty breathing, and vomiting, and may require removal of the device. Acute pancreatitis, also reported following implantation of these two gastric balloons, is caused by compression of the gastrointestinal system when the balloon is implanted. Further research is required to determine what is needed to rectify these issues.

According to GlobalData research, the gastric balloon segment of the bariatric surgery devices market is expected to increase in the coming years. Since approval in 2015, the market in the US has grown rapidly and already holds a 6% market share in the US, but the growth of this market may be jeopardised if safety concerns continue to arise with saline-filled gastric balloons.

Related Companies

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU